HIGHLIGHTS
- who: Zefan Liu et al. from the (Airport), Sichuan University, Chengdu , have published the Article: Small-Molecule PROTACs for Cancer Immunotherapy, in the Journal: Molecules 2022, 5439 of /2022/
- future: Despite the attractive prospect of applying PROTAC to immuno-oncology few studies have focused on this issue which might be attributed to the immature concepts and approaches.
SUMMARY
The recent decades witnessed the bloom of tumor immunotherapy. Most Since firstly proposed in 2001 by Craig M. Crews, this technology has revolutionized compounds competitively bind with the catalytic_site, inhibit kinase phosphorylation, or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.